Artificial cardiac pacemaker

FineHeart Widens International IP Protection for FlowMaker®

Retrieved on: 
Tuesday, February 20, 2024
Medical Devices, Surgery, Hospitals, Patent Law, Health Technology, Professional Services, Cardiology, Other Health, Biotechnology, Health, Heart rate, Artificial cardiac pacemaker, Multimedia, Patent, Patient, Medical device

FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.

Key Points: 
  • FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.
  • 3 new U.S. patents, a 3rd headline patent in China, 2 patents in India and in Japan strengthen FineHeart's international reputation, particularly in the Asian markets which are highly protective and difficult to access in terms of intellectual and industrial protection.
  • We are also very proud of our patent in Japan, where the excellence of our technology is recognised in a fast moving medical device market.
  • The technological innovations of the FlowMaker® underline our ongoing commitment to improving cardiac care for all patients worldwide."

Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer

Retrieved on: 
Wednesday, September 27, 2023
MDIC, Hospital, Boston Scientific, Artificial cardiac pacemaker, Chief commercial officer, ECG, CCO, U.S. FDA, Organization, Hunting, Heart, Patient, Growth, RPM, FDA, Management, Medical device, Implications of U.S. gene patent invalidation on Australia

CAMBRIDGE, Mass., Sept. 27, 2023 /PRNewswire/ -- Implicity, a leader in remote patient monitoring (RPM) and cardiac data management solutions, announced that Jon Hunt, PhD., has joined the company as its new Chief Commercial Officer (CCO), North America. In this role, Hunt will focus on business and sales strategies for the U.S. market to maximize growth, scale operations, and support technological innovations that help meet the growing demand for remote cardiac monitoring.

Key Points: 
  • Most recently, Hunt served as Executive Vice President and Chief Business Officer at HeartBeam (NASDAQ: BEAT), a cardiac technology company that developed the first 3D vector ECG platform for heart attack detection.
  • As a vital member of the senior leadership team, he played a critical role in taking the company public.
  • Prior to HeartBeam, Hunt held multiple leadership positions at organizations such as the Medical Device Innovation Consortium (MDIC), Cryterion Medical and Cameron Health.
  • "I could not be more excited to join the Implicity team at this important juncture," said Hunt.

Boundary Bay Veterinary Specialty Hospital Moves to Surrey

Retrieved on: 
Tuesday, May 9, 2023
Health, Veterinary, Other Health, Dentistry, Human, Port Mann Bridge, Internal medicine, Artificial cardiac pacemaker, Ontario Highway 115, Skull, Multimedia, Google Images, Hospital, Port Mann, Pet, Nursing care plan, Cardiology, Trauma, Death, Neurology, Family, Veterinary medicine

Boundary Bay Veterinary Specialty Hospital ( BBVSH ) - one of only two certified Level 1 emergency animal hospitals in Canada - has moved to a new location in Surrey.

Key Points: 
  • Boundary Bay Veterinary Specialty Hospital ( BBVSH ) - one of only two certified Level 1 emergency animal hospitals in Canada - has moved to a new location in Surrey.
  • View the full release here: https://www.businesswire.com/news/home/20230509005384/en/
    Boundary Bay Veterinary Specialty Hospital emergency and treatment area.
  • Unlike a family veterinarian which is like a GP or family doctor in human medicine, Boundary Bay Veterinary Specialty Hospital is more analogous to a general hospital for humans, with services like an ER trauma center, board-certified specialists, and specialized procedures to address the life-threatening situations that happen to pets.
  • BBVSH is also one of only a few veterinary hospitals in Canada to hire a veterinary social worker who provides support to clients whose pets have suffered trauma or sometimes even death.

California Releases New Album - "California Loves You"

Retrieved on: 
Thursday, January 19, 2023
Music, Dion, Radio, Mellotron, Billboard, R, Bass, Laurie Records, Perfect World, Britpop, Fleetwood Mac, See You in September, Artificial cardiac pacemaker, Jeans On, Tropics, Optimism, Multimedia, LES, American Bandstand, Singing

DENVER, Jan. 19, 2023 /PRNewswire/ -- Fresh off an unprecedented run of nine consecutive #1 international hits on the Radio Indie Alliance chart, veteran singer/songwriter Les Fradkin and his wife and creative partner, Loretta Pieper Fradkin, resurrect California – the name of Les's classic 70s and 80s band – for their latest album whose very title, "California Loves You", reflects their sunny and infectious optimism as they chronicle the stages of a modern-day romantic relationship.

Key Points: 
  • Its release coincides with the 50th Anniversary of the original California's signing to Laurie Records, well known for its recordings by Dion and Gerry and the Pacemakers.
  • The album's summery lead single "Perfect World" – recently broke through in 2022 on the Billboard charts, rising to #70 on the Top 100.
  • California had several Hit Singles during that time period including "See You In September", "Jeans On", "Summer Fun Medley" and "He's Almost You".
  • California returns with Les Fradkin - Vocals, Mellotron, Piano, Bass, Guitars, Ztar, Songwriter and Co-Production and Loretta Pieper Fradkin - Vocals, Songwriter and Co-Production.

Global Pacemakers Pipeline Insight and Competitive Landscape 2022: Featuring Key Players Medtronic, Boston Scientific Corporation, Biotronik Se & Co, LivaNova & Abbott Laboratories - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 27, 2022
Biotechnology, Health, Medical Devices, Acquisition, Blood, Physician, Competitive landscape, Food, CRT, Metal electrode leadless face, Degenerative disease, UCLA, Implantable cardioverter-defibrillator, News, Heart failure, Food and Drug Administration, Ageing, Technology, FDA, High, Heart, Medtronic, Growth, Cardiac arrest, Population, THI, The Texas Heart Institute, Nature, Prevalence, Medical device, Oil, Artificial cardiac pacemaker

This "Pacemakers-Pipeline Insight and 2022," report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Pacemakers pipeline landscape.

Key Points: 
  • This "Pacemakers-Pipeline Insight and 2022," report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Pacemakers pipeline landscape.
  • The Pacemakers market is expected to undergo significant growth in the approaching years owning to an increasing prevalence of cardiovascular disorders around the world.
  • This report provides a detailed study of the emerging pacemakers along with competitive landscape to help better understand the emerging pacemaker devices.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

Global Pacemakers Medical Devices Pipeline Market Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 5, 2022
Medical Devices, Health, Artificial cardiac pacemaker, Electrode, Heart, Muscle tissue, Medical device

The "Pacemakers - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pacemakers - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • "Pacemakers - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Pacemakers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    In-depth analysis of the product's current stage of development, territory and estimated launch date

Global Cardiac Bio Implant Devices Market Report 2022: Forecasts, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis, 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 3, 2022
Medical Devices, Health, COVID-19, Globe, Cardiac resynchronization therapy, Projection, Degenerative disease, Mortality, CRT, Budget, Stroke, Insight, Moyamoya disease, Heart failure, Management of heart failure, Oxygen, Cardiovascular disease, CRTS, Prevalence, Implantable cardioverter-defibrillator, Sudden death, Diabetes, Blood, Obesity, ICDS, Conditional sentence, Smoking, CSR, CAGR, Lists of schools in England, Alcoholism, Nutrient, Awareness, Hypertension, Risk, Medical device, Pharmaceutical industry, Death, Arrhythmia, Artificial cardiac pacemaker, Growth

The "Global Cardiac Bio Implant Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cardiac Bio Implant Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Hence, Cardiac Bio Implant Devices are electronic or mechanical implantable devices developed to aid in the treatment of cardiac disorders.
  • The increasing prevalence and awareness of cardiovascular disorders drive the Global Cardiac Bio Implant Devices Market.
  • However, the global Cardiac Bio Implant Devices market recovered as different government authorities began to break the enforced lockdowns in 2020.

Global Cardiac Rhythm Management Devices Market Research Report to 2027 - Featuring Abbott Laboratories, ACS Diagnostics and Biotronik Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, April 8, 2022
Health, Medical Devices, Cardiology, CAGR, USD, Investment, Artificial cardiac pacemaker, Certification, Technology, COVID-19, Defibrillation, R, Cardiac resynchronization therapy, Uncertainty, Medical device

What is the market size and forecast of the Global Cardiac Rhythm Management Devices Market?

Key Points: 
  • What is the market size and forecast of the Global Cardiac Rhythm Management Devices Market?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Rhythm Management Devices Market?
  • What is the market share of the leading vendors in the Global Cardiac Rhythm Management Devices Market?
  • What modes and strategic moves are considered suitable for entering the Global Cardiac Rhythm Management Devices Market?

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 4, 2022
Health, Medical Devices, Cardiology, Growth, Tachycardia, CRT, CE marking, USD, Patient, Gallant, Abbott, Medtronic, Boston Scientific, Korea Disease Control and Prevention Agency, Degenerative disease, Adoption, Center, COVID-19, CAGR, Swedish Transport Agency, AED, Program, Prevalence, CDC, Artificial cardiac pacemaker, Defibrillation, Arrhythmia, Cardiac resynchronization therapy, Survival, CRM, ICD, Chapter Three, Medical device, Fine chemical

The "Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT-D, CRT-P)), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT-D, CRT-P)), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global cardiac rhythm management devices market size is anticipated to reach USD 31.9 billion by 2030.
  • The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders.
  • The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices.

2021 Cardiac Rhythm Management Devices Medical Devices Pipeline Product Landscape Report - ResearchAndMarkets.com

Retrieved on: 
Monday, January 10, 2022
Health, Medical Devices, Cardiology, Artificial cardiac pacemaker, ICD, Implantable loop recorder, Implantable cardioverter-defibrillator, CRT, Heart, Arrhythmia, CRM, Medical device, Pharmaceutical industry

The "Cardiac Rhythm Management Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiac Rhythm Management Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    The report enables you to:
    In-depth analysis of the product's current stage of development, territory and estimated launch date